esmolol has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
| Christou, A; Fournarakis, GM; Koutouzis, MJ; Maisel, AS; Nikolaou, NI; Patsilinakos, SP; Rompola, A | 1 |
1 review(s) available for esmolol and Acute Coronary Syndrome
| Article | Year |
|---|---|
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
1 other study(ies) available for esmolol and Acute Coronary Syndrome
| Article | Year |
|---|---|
B-type natriuretic peptide blood levels identify patients with non-ST elevation acute coronary syndromes at high risk for complications during intravenous beta-blocker infusion.
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Arrhythmias, Cardiac; Biomarkers; Blood Pressure; Drug Administration Schedule; Echocardiography; Female; Greece; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Propanolamines; Retrospective Studies | 2011 |